Keyword

repaglinide

Description: Repaglinide is an oral antidiabetic medication that stimulates insulin release and is used to treat type 2 diabetes.
Wikidata ID: wiki/Q2195995
OpenAlex ID: keywords/repaglinide
2009 · A Kalliokoski, M Niemi · British Journal of Pharmacology · 1,080
2002 · Peter Proks, Frank Reimann, et al. · Diabetes · 589
2004 · Katherine Esposito, Dario Giugliano, et al. · Circulation · 463
2005 · M NIEMI, J BACKMAN, et al. · Clinical Pharmacology & Therapeutics · 379
2005 · Kathrin Maedler, Richard D. Carr, et al. · The Journal of Clinical Endocrinology & Metabolism · 362
2004 · David G Bailey, George K Dresser · American Journal of Cardiovascular Drugs · 270
2009 · Antoinette Moran, Penelope Pekow, et al. · Diabetes Care · 265
2001 · Anne Dornhorst · The Lancet · 240
2005 · L KAJOSAARI, M NIEMI, et al. · Clinical Pharmacology & Therapeutics · 229
2003 · Tanja Busk Bidstrup, Inga Bjørnsdottir, et al. · British Journal of Clinical Pharmacology · 228
2012 · Yanguang Cao, William J. Jusko · Journal of Pharmacokinetics and Pharmacodynamics · 221
1999 · Arshag D. Mooradian, Jerome E. Thurman · Drugs · 200
2004 · Julio Rosenstock, David R. Hassman, et al. · Diabetes Care · 199
1999 · Thomas Marbury, Won-Chin Huang, et al. · Diabetes Research and Clinical Practice · 193
2011 · Shailesh T. Prajapati, Charmi G. Patel, et al. · ISRN Pharmaceutics · 188
1977 · J Kowalewski · Progress in Nuclear Magnetic Resonance Spectroscopy · 188
Works count: 2,131
Citation count: 37,970
Year
Topic
Type